03694nam 22006494a 450 991101930640332120200520144314.09786610271191978128027119912802711919780470861196047086119397804708611580470861150(CKB)111090529061268(EBL)189682(SSID)ssj0000103158(PQKBManifestationID)11113643(PQKBTitleCode)TC0000103158(PQKBWorkID)10061099(PQKB)10706289(MiAaPQ)EBC189682(OCoLC)85820770(Perlego)2750745(EXLCZ)9911109052906126820040825d2004 uy 0engurcn|||||||||txtccrAnaphylaxisChichester ;Hoboken, NJ John Wiley & Sons20041 online resource (308 p.)Novartis Foundation symposium ;257"Symposium on Anaphylaxis, held at the Novartis Foundation, 25-27 February 2003; editors, Gregory Bock (organizer) and Jamie Goode."--Contents p.9780470861141 0470861142 Includes bibliographical references and indexes.ANAPHYLAXIS; Contents; Participants; Chair's introduction; History and classification of anaphylaxis; Discussion; Rethinking Th2 antibody responses and allergic sensitization; Discussion; General discussion I; The high affinity receptor for IgE, FceRI; Discussion; Effector cells of anaphylaxis: mast cells and basophils; Discussion; Cytokine enhancement of anaphylaxis; Discussion; General discussion II; Patterns of anaphylaxis: acute and late phase features of allergic reactions; Discussion; Fatal anaphylaxis in the UK, 1992-2001; Discussion; The human heart as a shock organ in anaphylaxisDiscussion General discussion III; Food-induced anaphylaxis; Discussion; Anaphylaxis to insect venom; Discussion; Anaphylaxis to anaesthetic drugs; Discussion; General discussion IV; The radiocontrast molecule in anaphylaxis. A surprising antigen; Discussion; General discussion V Fatal course of Vespula venom immunotherapy: pretreatment withdrawal of the b blocker may have been involved; Epinephrine (adrenaline) in the first-aid, out-of-hospital treatment of anaphylaxis; Discussion; New approaches for the treatment of anaphylaxis; DiscussionPatient's perspective and public policy regarding anaphylaxis Discussion; Final discussion; Index of contributors; Subject indexAnaphylaxis is an immediate-type allergic reaction involving the whole organism. It is the most life-threatening allergic condition. Although there are few exact epidemiological data regarding prevalence, estimates regarding insect sting anaphylaxis range from 1-3% in the general population, but much higher values have been reported by some authors for food and drug-induced anaphylaxis. Anaphylaxis is the main acute killer of allergic individuals.Although anaphylaxis was discovered at the beginning of the 20th century, there are still many unresolved issues. These include non-IgE-mediatedNovartis Foundation symposium ;257.AnaphylaxisCongressesAnaphylaxis614.5/993Bock Gregory322650Goode Jamie283336Novartis Foundation.MiAaPQMiAaPQMiAaPQBOOK9911019306403321Anaphylaxis4421691UNINA